China has launched a multi-agency effort to give the public better access to commonly used medications at relatively low prices, China Daily reported Wednesday.
Eight government departments, including the National Health and Family Planning Commission (NHFPC), National Development and Reform Commission, China Food and Drug Administration, and Ministry of Finance, have issued a joint notice on securing supplies of commonly used low-priced drugs.
“A list of such drugs is expected to be publicized by June, and the producers of the drugs will be entitled to the right of pricing according to production costs and the market situation,” NHFPC drug administration chief Zheng Hong was quoted as saying.
This means that government price limits on these commonly used drugs will be eliminated, Zheng said.
The initiative was in response to shortages of commonly used, low-priced drugs. Last year, people suffering from hyperthyroidism reported having difficulty in buying the low-priced medicine Tapazole. A 100-tablet bottle of the drug costs around 2.50 yuan (40 US cents) while imported ones are priced more than 10 times that, the report said.
– Contact HKEJ at [email protected]